Please refer the Attachment
Awaiting price reaction for this filing.
The board of Medinova Diagnostic Services informed that the NCLT Hyderabad Bench has sanctioned the scheme of amalgamation of Medinova (Transferor Company) with Vijaya Diagnostic Centre Limited (Transferee Company) via its order dated October 13, 2025. The appointed date for the merger is April 1, 2024, and the scheme will become effective once the certified copy of the NCLT order is filed with the Registrar of Companies, Hyderabad. As per the share exchange ratio, every 22 equity shares of Medinova (face value INR 10) will entitle the shareholder to 1 equity share of Vijaya Diagnostic (face value INR 1). The record date to identify eligible Medinova shareholders has been fixed as Tuesday, November 25, 2025. The board also approved the unaudited standalone and consolidated financial results for Q2 and H1 FY26 ended September 30, 2025.
Medinova shareholders will receive shares of Vijaya Diagnostic Centre in exchange for their Medinova holdings as per the 22:1 ratio on the record date, effectively meaning Medinova will cease to exist as a separate listed entity post-merger. Existing Medinova investors should hold their shares until the record date to be eligible for the share entitlement.